2026³â 07¿ù 13ÀÏ ¿ù¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Calyxt Completes Second Year of Field Trials of its High Oleic Soybean Product

´º½ºÀÏÀÚ: 2015-11-02

NEW BRIGHTON, Minn.--()--Calyxt, Inc., a Minnesota-based company focusing on developing healthier food products to benefit both consumers and farmers, today announced that it has completed the second year of multi-location field trials in Minnesota and South Dakota of its high oleic/no trans fat soybean variety.

For many food applications, standard soybean oil is hydrogenated to improve heat stability and shelf life. This process also increases the amount of saturated fatty acids and creates trans-fats, which have been linked to numerous human health issues. Calyxt has created a non-transgenic variety of soybean with elevated levels of monounsaturated (oleic) fatty acids and decreased levels of saturated fatty acids (palmitic and acid) and polyunsaturated fatty acids (linoleic and linolenic). Compared to standard soybean oil, the Calyxt soybean variety generates oil that eliminates the need for hydrogenation.

The oleic acid content (81%) achieved in Calyxt’s high oleic soybean variety is equal to or exceeds the oleic acid level of transgenic, high oleic soybean varieties currently being grown in the U.S. In addition, the yield of the Calyxt variety in these field trials was equivalent to current conventional varieties, putting Calyxt on the road for a commercial launch of its non-transgenic variety in the next couple of years. Counter-season seed production is currently underway to facilitate a commercial launch in the U.S. while additional field trials are conducted over the next few growing seasons.

“With the recent ban (July 2015) of trans fat products by the FDA, high oleic soybean varieties will likely become the next commodity soybean. The very high amount of oleic acid consistently observed in our field trials demonstrates that our high oleic soybean variety would not only be non-transgenic but also best-in-class to other transgenic high oleic varieties, positioning us as a potential leader,” said Dan Voytas, Chief Scientific Officer of Calyxt, Inc.

About Calyxt

Founded in 2010, Calyxt, Inc. (previously Cellectis plant sciences, Inc.) is based in New Brighton, Minnesota (USA). The company aims to create healthier crop products such as low trans fat soybean oil, cold-storable potato, gluten reduced wheat and low saturated fat canola oil for the food and agriculture industries. Calyxt is developing a network of partnerships in order to secure accessibility of its food products to consumers.

For further information please visit our website: www.calyxt.com

Calyxt™ and the corporate logo are trademarks owned by Calyxt, Inc.



 Àüü´º½º¸ñ·ÏÀ¸·Î

FIFA World Cup¢â Fans Embrace Referee View as Lenovo AI Brings Viewers Closer to the Pitch
Galderma Releases Global Survey on Evolving Patient and HCP Expectations in Anti‑Wrinkle Treatments
LG Electronics Establishes Robotics Business Center to Accelerate Future Growth
VeriSilicon Drives Commercial Adoption of AV2 Across Next-Generation Video and Streaming Applications
The Open Group Releases OSDU¢ç Data Platform Standard, Version 1.0
Online Video Subscription Reached 2.24 Billion in 2025 Ahead of Projected Slowdown in 2026
SLB Collaborates with Qualcomm on Edge AI Solutions for Energy Operations

 

New Method Enables Structural Determination of Diverse Phenolic Compou...
GlobalFoundries, Qualinx Unveil Europe¡¯s First Sovereign Flow for Sec...
Netflix to Reach 400 Million Subscribers by 2031, Maintaining Global S...
IQM Opens First U.S. Quantum Tech Center at University of Maryland Dis...
HistoSonics Advances Histotripsy, Submits FDA Application for Kidney T...
Boomi Adds Snowflake Cortex Agents Support to Agentstudio to Enable Un...
NIQ Unveils Six New AI-Powered Capabilities at C360, Executing on Its ...

 


°øÁö»çÇ×
¹Ìµð¾î¿Í M• Mediaour ØÚ体ä² ØÚô÷ä² ¿¥¿À MO ØÚä²
¾Ë¸®¾Ë A⋮⋮⋮ Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
À£ÇÁ·Ò W⋮⋮⋮ Welfrom 卫ÜØ êÛÝ£
¹ÙÀÌ¿ÀÀÌ´Ï B⋮ BIOINI ù±药研 ¹ÙÀÌ¿ÀÀÌ´Ï·¦ BIOINILAB ...
º£³×ÀÍ ¡Õ Beneik 宝Ò¬ìÌ, À̺ñÁî eBizh æ¶币òª EZ æ¶òª
¿¡³ÊÀÌÀ¯ ¡Õ¡Õ EnerEU 额Òö äþÒö
´º½ºÁö Áß¹®Ç¥±â´Â À½Â÷ Ç¥±â¹æ½Ä '纽ÞÙó¢ ´Ï¿ì½ºÁö'
¾Ë¸®À¯ºñ ^v Alliuv ä¹备 AV ä¹êó备, ¾Ë¶ã =^= Althle ä¹÷åìÌ
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º ¡ÕC À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¾ËÇÁ·Ò ^ Alfrom ä¹尔ÜØ ä¹ì³ÜØ, ¿ÃÇÁ·Ò A⋮⋮ Allfrom &...

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..